KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $3.78 $7.64 Thursday, 25th Apr 2024 FATE stock ended at $3.87. This is 10.00% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 9.79% from a day low at $3.78 to a day high of $4.15.
90 days $3.78 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Jul 14, 2021 $81.91 $82.00 $76.82 $77.16 929 768
Jul 13, 2021 $85.95 $86.02 $81.21 $81.41 629 614
Jul 12, 2021 $90.63 $91.35 $85.35 $85.92 652 093
Jul 09, 2021 $87.80 $91.54 $85.19 $90.45 556 138
Jul 08, 2021 $83.63 $88.28 $82.28 $87.21 904 578
Jul 07, 2021 $87.52 $88.60 $83.00 $86.31 1 451 271
Jul 06, 2021 $92.82 $93.50 $86.96 $87.39 934 522
Jul 02, 2021 $94.38 $94.95 $90.79 $92.80 834 363
Jul 01, 2021 $84.76 $95.38 $84.27 $94.29 1 287 549
Jun 30, 2021 $88.50 $90.65 $85.80 $86.79 1 177 576
Jun 29, 2021 $89.24 $91.39 $87.29 $89.16 851 336
Jun 28, 2021 $87.48 $90.80 $87.23 $89.12 948 981
Jun 25, 2021 $84.89 $85.73 $82.67 $84.55 777 354
Jun 24, 2021 $84.20 $88.42 $84.00 $84.84 622 691
Jun 23, 2021 $81.79 $84.00 $81.62 $83.53 571 399
Jun 22, 2021 $82.08 $82.11 $79.72 $81.42 564 207
Jun 21, 2021 $80.01 $82.17 $78.48 $81.90 977 205
Jun 18, 2021 $83.46 $84.81 $79.21 $80.23 1 516 013
Jun 17, 2021 $82.28 $86.17 $81.73 $84.21 1 463 559
Jun 16, 2021 $86.46 $87.76 $79.01 $82.65 1 147 087
Jun 15, 2021 $89.99 $90.62 $85.26 $86.79 1 081 544
Jun 14, 2021 $89.89 $90.99 $88.07 $89.97 915 704
Jun 11, 2021 $88.05 $90.99 $86.47 $89.75 1 070 421
Jun 10, 2021 $82.52 $88.95 $80.00 $88.42 1 827 637
Jun 09, 2021 $79.95 $84.65 $79.89 $82.87 1 330 804
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT